# A Study to Assess the Effect of Multiple Doses of Itraconazole, Gemfibrozil, or Carbamazepine on BMS-986278 in Healthy Participants

> **NCT05932303** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 47 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** BMS-986278
- **DRUG:** Itraconazole
- **DRUG:** Gemfibrozil
- **DRUG:** Carbamazepine

## Key facts

- **NCT ID:** NCT05932303
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-12
- **Primary completion:** 2023-10-23
- **Final completion:** 2023-10-23
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2023-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05932303

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05932303, "A Study to Assess the Effect of Multiple Doses of Itraconazole, Gemfibrozil, or Carbamazepine on BMS-986278 in Healthy Participants". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT05932303. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*